Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Int J Food Sci ; 2023: 9959998, 2023.
Article in English | MEDLINE | ID: mdl-38025395

ABSTRACT

Warm temperatures and drought conditions in the United States (US) Corn Belt in 2012 raised concern for widespread aflatoxin (AFL) contamination in Iowa corn. To identify the prevalence of AFL in the 2012 corn crop, the Iowa Department of Agriculture and Land Stewardship (IDALS) conducted a sample of Iowa corn to assess the incidence and severity of AFL contamination. Samples were obtained from grain elevators in all of Iowa's 99 counties, representing nine crop reporting districts (CRD), and 396 samples were analyzed by IDALS using rapid test methods. The statewide mean for AFL in parts per billion (ppb) was 5.57 ppb. Regions of Iowa differed in their incidence levels, with AFL levels significantly higher in the Southwest (SW; mean 15.13 ppb) and South Central (SC; mean 10.86 ppb) CRD (p < 0.05) regions of Iowa. This sampling demonstrated high variability among samples collected within CRD and across the entire state of Iowa in an extreme weather event year. In years when Iowa has AFL contamination in corn, there is a need for a proactive and preventive strategy to minimize hazards in domestic and export markets.

2.
Front Microbiol ; 14: 1248772, 2023.
Article in English | MEDLINE | ID: mdl-37720139

ABSTRACT

Introduction: Aflatoxin (AFL), a secondary metabolite produced from filamentous fungi, contaminates corn, posing significant health and safety hazards for humans and livestock through toxigenic and carcinogenic effects. Corn is widely used as an essential commodity for food, feed, fuel, and export markets; therefore, AFL mitigation is necessary to ensure food and feed safety within the United States (US) and elsewhere in the world. In this case study, an Iowa-centric model was developed to predict AFL contamination using historical corn contamination, meteorological, satellite, and soil property data in the largest corn-producing state in the US. Methods: We evaluated the performance of AFL prediction with gradient boosting machine (GBM) learning and feature engineering in Iowa corn for two AFL risk thresholds for high contamination events: 20-ppb and 5-ppb. A 90%-10% training-to-testing ratio was utilized in 2010, 2011, 2012, and 2021 (n = 630), with independent validation using the year 2020 (n = 376). Results: The GBM model had an overall accuracy of 96.77% for AFL with a balanced accuracy of 50.00% for a 20-ppb risk threshold, whereas GBM had an overall accuracy of 90.32% with a balanced accuracy of 64.88% for a 5-ppb threshold. The GBM model had a low power to detect high AFL contamination events, resulting in a low sensitivity rate. Analyses for AFL showed satellite-acquired vegetative index during August significantly improved the prediction of corn contamination at the end of the growing season for both risk thresholds. Prediction of high AFL contamination levels was linked to aflatoxin risk indices (ARI) in May. However, ARI in July was an influential factor for the 5-ppb threshold but not for the 20-ppb threshold. Similarly, latitude was an influential factor for the 20-ppb threshold but not the 5-ppb threshold. Furthermore, soil-saturated hydraulic conductivity (Ksat) influenced both risk thresholds. Discussion: Developing these AFL prediction models is practical and implementable in commodity grain handling environments to achieve the goal of preventative rather than reactive mitigations. Finding predictors that influence AFL risk annually is an important cost-effective risk tool and, therefore, is a high priority to ensure hazard management and optimal grain utilization to maximize the utility of the nation's corn crop.

3.
J Prof Nurs ; 42: 301-307, 2022.
Article in English | MEDLINE | ID: mdl-36150874

ABSTRACT

BACKGROUND: When the COVID-19 pandemic was declared in March 2020, nursing programs made rapid decisions regarding clinical placement experiences for students. In many nursing programs, this meant ending clinical placements early, delaying clinical courses, and moving clinical courses to simulation. PURPOSE: The purpose of this study was to explore LPN-BN students' experiences in clinical courses during the COVID-19 pandemic. METHOD: A qualitative descriptive approach was employed in this study. Fifteen semi-structured conversational interviews with nursing students and recent graduates were conducted. Inductive content analysis was used to analyse the data. RESULTS: Four main concepts were identified: (1) logistics of learning; (2) shifts in clinical learning; (3) mental health matters; (4) readiness to practice. CONCLUSION: It is important to understand the experience of nursing students as this is an inordinately stressful and impressionable time for them. Insight into the student experience, will inform educators in the areas of curriculum and competency-based evaluation as well as supports for student mental health and well-being.


Subject(s)
COVID-19 , Education, Nursing, Baccalaureate , Students, Nursing , COVID-19/epidemiology , Humans , Learning , Pandemics , Qualitative Research , Students, Nursing/psychology
4.
Mycotoxin Res ; 38(2): 107-115, 2022 May.
Article in English | MEDLINE | ID: mdl-35338441

ABSTRACT

Milk is susceptible to aflatoxin M1 (AFM1) contamination when dairy cattle consume feed contaminated with aflatoxins and is considered as a public health concern. This pilot study assessed the prevalence and amount of total aflatoxin contamination in commercially available dairy feed and the corresponding AFM1 contamination in raw milk from samples collected at farms using local, commercially available dairy feed across Rwanda's five provinces. The inclusion criteria to select dairy farm participants were (1) to have at least two cows and (2) use of commercially prepared dairy feeds. Importantly, the majority of cattle rearing households in Rwanda rely principally on grazing or other freely available feedstock, rather than on commercially prepared feeds. In total, 170 raw milk samples were collected during one sampling period from dairy farms using commercially prepared dairy feeds. In addition, 154 dairy feed samples were collected simultaneously with the milk samples. These farms were previously targeted in a larger study measuring aflatoxin contamination of Rwandan feeds and feed ingredients. The mean AFM1 concentration in these samples was 0.89 ± 1.64 µg/l (median: 0.33 µg/l) with a maximum of 14.5 µg/l. Maize bran was the principal dairy feed ingredient used by farmers in the sampling, representing more than 65% of the total feed samples collected, with mean aflatoxin concentration of 90.5 µg/kg (median 32.3 µg/kg). The authors note that this preliminary sampling is not generalizable across Rwandan milk production and consumption; the limited pilot study presented here was not designed with the robustness necessary for broad-scale generalization. Thus, the data presented should not be broadly applied outside of the context of the study.


Subject(s)
Aflatoxin M1 , Aflatoxins , Aflatoxin M1/analysis , Aflatoxins/analysis , Animal Feed/analysis , Animals , Cattle , Farms , Female , Food Contamination/analysis , Humans , Milk/chemistry , Pilot Projects , Rwanda
5.
Toxins (Basel) ; 11(5)2019 05 14.
Article in English | MEDLINE | ID: mdl-31091663

ABSTRACT

Mycotoxins are fungal metabolites that contaminate crops, food, and animal feeds. Aflatoxins and fumonisins are among the mycotoxins that have been increasingly reported to affect health and productivity of livestock globally. Given that the health and productivity of livestock can directly influence human food safety and security, a study was conducted to assess the levels and factors for aflatoxin and fumonisin contamination in feed and feed ingredients in Rwanda. Aflatoxins and fumonisins were analyzed in 3328 feed and feed ingredient samples collected at six time points between March and October 2017 in all 30 districts of Rwanda. Of the 612 participants providing samples, there were 10 feed processors, 68 feed vendors, 225 dairy farmers, and 309 poultry farmers. Enzyme-Linked Immunosorbent Assay (ELISA) was used for aflatoxin and fumonisin analyses. Mean aflatoxin levels of 108.83 µg/kg (Median (MD): 43.65 µg/kg), 103.81µg/kg (MD: 48.4 µg/kg), 88.64 µg/kg (MD: 30.90 µg/kg), and 94.95 µg/kg (MD: 70.45 µg/kg) were determined for dairy farmers, poultry farmers, feed vendors, and feed processors, respectively. Mean fumonisin levels were 1.52 mg/kg (MD: 0.71 mg/kg), 1.21 mg/kg (MD: 0.56 mg/kg), 1.48 mg/kg (MD: 0.76 mg/kg), and 1.03 mg/kg (MD: 0.47 mg/kg) for dairy farmers, poultry farmers, feed vendors, and feed processors, respectively. Aflatoxin contamination was significantly affected by time of sampling and district from which feed samples originated (p < 0.05). Fumonisins did not show any correlation trends. Ninety-two percent of survey participants were unaware of aflatoxins and fumonisins and their adverse effects. This study has provided the basic understanding of the extent of feed contamination across the country and has established a baseline for future interventions in Rwanda. Further studies are needed to explore strategies for mitigating mycotoxins in the feed value chain in Rwanda.


Subject(s)
Aflatoxins/analysis , Animal Feed/analysis , Food Contamination/analysis , Fumonisins/analysis , Adolescent , Adult , Environmental Monitoring , Female , Humans , Male , Risk Factors , Rwanda , Surveys and Questionnaires , Young Adult
6.
Article in English | MEDLINE | ID: mdl-26807606

ABSTRACT

Mycotoxins, toxins produced by fungi that colonise food crops, can pose a heavy economic burden to the US corn industry. In terms of economic burden, aflatoxins are the most problematic mycotoxins in US agriculture. Estimates of their market impacts are important in determining the benefits of implementing mitigation strategies within the US corn industry, and the value of strategies to mitigate mycotoxin problems. Additionally, climate change may cause increases in aflatoxin contamination in corn, greatly affecting the economy of the US Midwest and all sectors in the United States and worldwide that rely upon its corn production. We propose two separate models for estimating the potential market loss to the corn industry from aflatoxin contamination, in the case of potential near-future climate scenarios (based on aflatoxin levels in Midwest corn in warm summers in the last decade). One model uses the probability of acceptance based on operating characteristic (OC) curves for aflatoxin sampling and testing, while the other employs partial equilibrium economic analysis, assuming no Type 1 or Type 2 errors, to estimate losses due to proportions of lots above the US Food and Drug Administration (USFDA) aflatoxin action levels. We estimate that aflatoxin contamination could cause losses to the corn industry ranging from US$52.1 million to US$1.68 billion annually in the United States, if climate change causes more regular aflatoxin contamination in the Corn Belt as was experienced in years such as 2012. The wide range represents the natural variability in aflatoxin contamination from year to year in US corn, with higher losses representative of warmer years.


Subject(s)
Aflatoxins/analysis , Crops, Agricultural/chemistry , Crops, Agricultural/economics , Food Contamination/analysis , Food Contamination/economics , Zea mays/chemistry , United States
7.
Toxins (Basel) ; 6(9): 2804-25, 2014 Sep 22.
Article in English | MEDLINE | ID: mdl-25247264

ABSTRACT

Mycotoxins in maize grain intended for ethanol production are enriched in co-product dried distiller's grains and solubles (DDGS) and may be detrimental to yeast in fermentation. This study was conducted to examine the magnitude of fumonisin enrichment in DDGS and to analyze the impacts of insect injury, Fusarium ear rot severity, and fumonisin contamination on final ethanol yield. Samples of naturally-contaminated grain (0 to 35 mg/kg fumonisins) from field trials conducted in 2008-2011 were fermented and DDGS collected and analyzed for fumonisin content. Ethanol yield (determined gravimetrically) was unaffected by fumonisins in the range occurring in this study, and was not correlated with insect injury or Fusarium ear rot severity. Ethanol production was unaffected in fumonisin B1-spiked grain with concentrations from 0 to 37 mg/kg. Bacillus thuringiensis (Bt) maize often has reduced fumonisins due to its protection from insect injury and subsequent fungal infection. DDGS derived from Bt and non-Bt maize averaged 2.04 mg/kg and 8.25 mg/kg fumonisins, respectively. Fumonisins were enriched by 3.0× for 50 out of 57 hybrid × insect infestation treatment combinations; those seven that differed were <3.0 (1.56 to 2.56×). This study supports the industry assumption of three-fold fumonisin enrichment in DDGS, with measurements traceable to individual samples. Under significant insect pest pressures, DDGS derived from Bt maize hybrids were consistently lower in fumonisins than DDGS derived from non-Bt hybrids.


Subject(s)
Animal Feed/analysis , Ethanol/metabolism , Food Contamination/analysis , Fumonisins/analysis , Zea mays , Animals , Fermentation , Fusarium , Lepidoptera , Plant Diseases , Plants, Genetically Modified , Zea mays/chemistry , Zea mays/genetics , Zea mays/metabolism , Zea mays/microbiology
8.
J Agric Food Chem ; 62(27): 6463-72, 2014 Jul 09.
Article in English | MEDLINE | ID: mdl-24964132

ABSTRACT

Field trials were conducted from 2007 to 2010 to compare grain fumonisin levels among non-Bt maize hybrids and Bt hybrids with transgenic protection against manual infestations of European corn borer (ECB) and Western bean cutworm (WBC). HPLC and ELISA were used to measure fumonisin levels. Results of the methods were highly correlated, but ELISA estimates were higher. Bt hybrids experienced less insect injury, Fusarium ear rot, and fumonisin contamination compared to non-Bt hybrids. WBC infestation increased fumonisin content compared to natural infestation in non-Bt and hybrids expressing Cry1Ab protein in five of eight possible comparisons; in Cry1F hybrids, WBC did not impact fumonisins. These results indicate that WBC is capable of increasing fumonisin levels in maize. Under WBC infestation, Cry1F mitigated this risk more consistently than Cry1Ab or non-Bt hybrids. Transgenically expressed Bt proteins active against multiple lepidopteran pests can provide broad, consistent reductions in the risk of fumonisin contamination.


Subject(s)
Chromatography, High Pressure Liquid/methods , Enzyme-Linked Immunosorbent Assay/methods , Fumonisins/analysis , Moths/physiology , Mycotoxins/analysis , Plants, Genetically Modified/chemistry , Zea mays/chemistry , Animals , Food Contamination/analysis , Fumonisins/metabolism , Fusarium/metabolism , Plant Diseases/microbiology , Plant Diseases/parasitology , Plant Diseases/prevention & control , Plants, Genetically Modified/microbiology , Plants, Genetically Modified/parasitology , Zea mays/microbiology , Zea mays/parasitology
9.
J Invest Dermatol ; 133(10): 2444-2452, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23698071

ABSTRACT

Epigenetic events, including covalent post-translational modifications of histones, have been demonstrated to have critical roles in tumor development and progression. The transcriptional coactivator p300/CBP possesses both histone acetyltransferase (HAT) activity and scaffolding properties that directly influence the transcriptional activation of targeted genes. We have used a potent and specific inhibitor of p300/CBP HAT activity, C646, in order to evaluate the functional contributions of p300/CBP HAT to tumor development and progression. Here we report that C646 inhibits the growth of human melanoma and other tumor cells and promotes cellular senescence. Global assessment of the p300 HAT transcriptome in human melanoma identified functional roles in promoting cell cycle progression, chromatin assembly, and activation of DNA repair pathways through direct transcriptional regulatory mechanisms. In addition, C646 is shown to promote sensitivity to DNA damaging agents, leading to the enhanced apoptosis of melanoma cells after combination treatment with cisplatin. Together, our data suggest that p300 HAT activity mediates critical growth regulatory pathways in tumor cells and may serve as a potential therapeutic target for melanoma and other malignancies by promoting cellular responses to DNA damaging agents that are currently ineffective against specific cancers.


Subject(s)
Benzoates/pharmacology , Cellular Senescence/drug effects , DNA Damage/drug effects , Enzyme Inhibitors/pharmacology , Melanoma/pathology , Pyrazoles/pharmacology , Skin Neoplasms/pathology , p300-CBP Transcription Factors/antagonists & inhibitors , Apoptosis/drug effects , Apoptosis/physiology , Cell Cycle/drug effects , Cell Cycle/physiology , Cell Line, Tumor , Cellular Senescence/physiology , DNA Damage/physiology , Epigenesis, Genetic/drug effects , Epigenesis, Genetic/physiology , Histone Acetyltransferases/antagonists & inhibitors , Histone Acetyltransferases/metabolism , Humans , Melanoma/genetics , Nitrobenzenes , Pyrazolones , Skin Neoplasms/genetics , p300-CBP Transcription Factors/genetics , p300-CBP Transcription Factors/metabolism
10.
Chembiochem ; 13(14): 2113-21, 2012 Sep 24.
Article in English | MEDLINE | ID: mdl-22961914

ABSTRACT

Histone acetyltransferase enzymes (HATs) are important therapeutic targets, but there are few cell-based assays available for evaluating the pharmacodynamics of HAT inhibitors. Here we present the application of a FRET-based reporter, Histac, in live-cell studies of p300/CBP HAT inhibition, by both genetic and pharmacologic disruption. shRNA knockdown of p300/CBP led to increased Histac FRET, thus suggesting a role for p300/CBP in the acetylation of the histone H4 tail. Additionally, we describe a new p300/CBP HAT inhibitor, C107, and show that it can also increase cellular Histac FRET. Taken together, these studies provide a live-cell strategy for identifying and evaluating p300/CBP inhibitors.


Subject(s)
p300-CBP Transcription Factors/antagonists & inhibitors , Acetylation , Animals , COS Cells , Cell Survival/drug effects , Chlorocebus aethiops , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Fluorescence Resonance Energy Transfer , RNA Interference , RNA, Small Interfering/metabolism , Recombinant Proteins/antagonists & inhibitors , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , p300-CBP Transcription Factors/genetics , p300-CBP Transcription Factors/metabolism
11.
Proc Natl Acad Sci U S A ; 108(19): 7814-9, 2011 May 10.
Article in English | MEDLINE | ID: mdl-21518915

ABSTRACT

Histone modifications are reported to show different behaviors, associations, and functions in different genomic niches and organisms. We show here that rapid, continuous turnover of acetylation specifically targeted to all K4-trimethylated H3 tails (H3K4me3), but not to bulk histone H3 or H3 carrying other methylated lysines, is a common uniform characteristic of chromatin biology in higher eukaryotes, being precisely conserved in human, mouse, and Drosophila. Furthermore, dynamic acetylation targeted to H3K4me3 is mediated by the same lysine acetyltransferase, p300/cAMP response element binding (CREB)-binding protein (CBP), in both mouse and fly cells. RNA interference or chemical inhibition of p300/CBP using a newly discovered small molecule inhibitor, C646, blocks dynamic acetylation of H3K4me3 globally in mouse and fly cells, and locally across the promoter and start-site of inducible genes in the mouse, thereby disrupting RNA polymerase II association and the activation of these genes. Thus, rapid dynamic acetylation of all H3K4me3 mediated by p300/CBP is a general, evolutionarily conserved phenomenon playing an essential role in the induction of immediate-early (IE) genes. These studies indicate a more global function of p300/CBP in mediating rapid turnover of acetylation of all H3K4me3 across the nuclei of higher eukaryotes, rather than a tight promoter-restricted function targeted by complex formation with specific transcription factors.


Subject(s)
Histones/chemistry , Histones/metabolism , p300-CBP Transcription Factors/metabolism , Acetylation , Animals , Binding Sites , Cell Line , Drosophila/genetics , Drosophila/metabolism , Drosophila Proteins/genetics , Drosophila Proteins/metabolism , Evolution, Molecular , Gene Knockdown Techniques , Genes, Immediate-Early , Genes, fos , Genes, jun , Histone Acetyltransferases/antagonists & inhibitors , Histone Acetyltransferases/genetics , Histone Acetyltransferases/metabolism , Histone Deacetylase Inhibitors/pharmacology , Humans , Hydroxamic Acids/pharmacology , Lysine/chemistry , Mice , Promoter Regions, Genetic , Species Specificity , p300-CBP Transcription Factors/antagonists & inhibitors , p300-CBP Transcription Factors/genetics
12.
Science ; 330(6011): 1689-92, 2010 Dec 17.
Article in English | MEDLINE | ID: mdl-21097901

ABSTRACT

Ghrelin is a gastric peptide hormone that stimulates weight gain in vertebrates. The biological activities of ghrelin require octanoylation of the peptide on Ser(3), an unusual posttranslational modification that is catalyzed by the enzyme ghrelin O-acyltransferase (GOAT). Here, we describe the design, synthesis, and characterization of GO-CoA-Tat, a peptide-based bisubstrate analog that antagonizes GOAT. GO-CoA-Tat potently inhibits GOAT in vitro, in cultured cells, and in mice. Intraperitoneal administration of GO-CoA-Tat improves glucose tolerance and reduces weight gain in wild-type mice but not in ghrelin-deficient mice, supporting the concept that its beneficial metabolic effects are due specifically to GOAT inhibition. In addition to serving as a research tool for mapping ghrelin actions, GO-CoA-Tat may help pave the way for clinical targeting of GOAT in metabolic diseases.


Subject(s)
Acyltransferases/antagonists & inhibitors , Enzyme Inhibitors/pharmacology , Ghrelin/metabolism , Glucose/metabolism , Peptides/pharmacology , Weight Gain/drug effects , Acylation , Animals , Cell Survival/drug effects , Drug Design , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/toxicity , Ghrelin/deficiency , Ghrelin/genetics , Glucose Tolerance Test , HeLa Cells , Homeostasis , Humans , Insulin/metabolism , Ion Channels/metabolism , Islets of Langerhans/drug effects , Islets of Langerhans/metabolism , Male , Membrane Proteins , Mice , Mice, Inbred C57BL , Mice, Knockout , Mitochondrial Proteins/metabolism , Peptides/chemical synthesis , Peptides/toxicity , Uncoupling Protein 2
13.
Chem Biol ; 17(5): 471-82, 2010 May 28.
Article in English | MEDLINE | ID: mdl-20534345

ABSTRACT

The histone acetyltransferase (HAT) p300/CBP is a transcriptional coactivator implicated in many gene regulatory pathways and protein acetylation events. Although p300 inhibitors have been reported, a potent, selective, and readily available active-site-directed small molecule inhibitor is not yet known. Here we use a structure-based, in silico screening approach to identify a commercially available pyrazolone-containing small molecule p300 HAT inhibitor, C646. C646 is a competitive p300 inhibitor with a K(i) of 400 nM and is selective versus other acetyltransferases. Studies on site-directed p300 HAT mutants and synthetic modifications of C646 confirm the importance of predicted interactions in conferring potency. Inhibition of histone acetylation and cell growth by C646 in cells validate its utility as a pharmacologic probe and suggest that p300/CBP HAT is a worthy anticancer target.


Subject(s)
Benzoates/chemistry , Enzyme Inhibitors/chemistry , Histone Acetyltransferases/antagonists & inhibitors , Pyrazoles/chemistry , p300-CBP Transcription Factors/antagonists & inhibitors , Acetylation , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Benzoates/pharmacology , Binding Sites , Binding, Competitive , Catalytic Domain , Cell Line, Tumor , Computer Simulation , Crystallography, X-Ray , Enzyme Inhibitors/pharmacology , Histone Acetyltransferases/metabolism , Ligands , Mice , Pyrazoles/pharmacology , Pyrazolones/chemistry , Small Molecule Libraries/chemistry , Structure-Activity Relationship , p300-CBP Transcription Factors/metabolism
14.
Biochim Biophys Acta ; 1774(12): 1500-7, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17997993

ABSTRACT

Salts inhibit the activity of sweet almond beta-glucosidase. For cations (Cl(-) salts) the effectiveness follows the series: Cu(+2), Fe(+2)>Zn(+2)>Li(+)>Ca(+2)>Mg(+2)>Cs(+)>NH(4)(+)>Rb(+)>K(+)>Na(+) and for anions (Na(+) salts) the series is: I(-)>ClO(4)(-)>(-)SCN>Br(-) approximately NO(3)(-)>Cl(-) approximately (-)OAc>F(-) approximately SO(4)(-2). The activity of the enzyme, like that of most glycohydrolases, depends on a deprotonated carboxylate (nucleophile) and a protonated carboxylic acid for optimal activity. The resulting pH-profile of k(cat)/K(m) for the beta-glucosidase-catalyzed hydrolysis of p-nitrophenyl glucoside is characterized by a width at half height that is strongly sensitive to the nature and concentration of the salt. Most of the inhibition is due to a shift in the enzymic pK(a)s and not to an effect on the pH-independent second-order rate constant, (k(cat)/K(m))(lim). For example, as the NaCl concentration is increased from 0.01 M to 1.0 M the apparent pK(a1)increases (from 3.7 to 4.9) and the apparent pK(a2)decreases (from 7.2 to 5.9). With p-nitrophenyl glucoside, the value of the pH-independent (k(cat)/K(m))(lim) (=9 x 10(4) M(-1) s(-1)) is reduced by less than 4% as the NaCl concentration is increased. There is a similar shift in the pK(a)s when the LiCl concentration is increased to 1.0 M. The results of these salt-induced pK(a) shifts rule out a significant contribution of reverse protonation to the catalytic efficiency of the enzyme. At low salt concentration, the fraction of the catalytically active monoprotonated enzyme in the reverse protonated form (i.e., proton on the group with a pK(a) of 3.7 and dissociated from the group with a pK(a) of 7.2) is very small ( approximately 0.03%). At higher salt concentrations, where the two pK(a)s become closer, the fraction of the monoprotonated enzyme in the reverse protonated form increases over 300-fold. However, there is no increase in the intrinsic reactivity, (k(cat)/K(m))(lim), of the monoprotonated species. For other enzymes which may show such salt-induced pK(a) shifts, this provides a convenient test for the role of reverse protonation.


Subject(s)
Hydrogen-Ion Concentration , Salts/pharmacology , beta-Glucosidase/metabolism , Anions/pharmacology , Cations/pharmacology , Enzyme Activation/drug effects , Glucose/analogs & derivatives , Glucose/metabolism , Models, Biological , Osmolar Concentration , Protein Binding/drug effects , Prunus/enzymology , beta-Glucosidase/antagonists & inhibitors
15.
J Med Chem ; 50(22): 5330-8, 2007 Nov 01.
Article in English | MEDLINE | ID: mdl-17924613

ABSTRACT

Serotonin N-acetyltransferase (arylalkylamine N-acetyltransferase, AANAT) is a member of the GCN5 N-acetyltransferase (GNAT) superfamily and catalyzes the penultimate step in the biosynthesis of melatonin; a large daily rhythm in AANAT activity drives the daily rhythm in circulating melatonin. We have used a structure-based computational approach to identify the first druglike and selective inhibitors of AANAT. Approximately 1.2 million compounds were virtually screened by 3D high-throughput docking into the active site of X-ray structures for AANAT, and in total 241 compounds were tested as inhibitors. One compound class, containing a rhodanine scaffold, exhibited low micromolar competitive inhibition against acetyl-CoA (AcCoA) and proved to be effective in blocking melatonin production in pineal cells. Compounds from this class are predicted to bind as bisubstrate inhibitors through interactions with the AcCoA and serotonin binding sites. Overall, this study demonstrates the feasibility of using virtual screening to identify small molecules that are selective inhibitors of AANAT.


Subject(s)
Arylalkylamine N-Acetyltransferase/antagonists & inhibitors , Arylalkylamine N-Acetyltransferase/chemistry , Enzyme Inhibitors/chemistry , Models, Molecular , Quantitative Structure-Activity Relationship , Acetyl Coenzyme A/antagonists & inhibitors , Acetyl Coenzyme A/chemistry , Animals , Arylalkylamine N-Acetyltransferase/biosynthesis , Binding Sites , Cells, Cultured , Crystallography, X-Ray , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/pharmacology , Melatonin/antagonists & inhibitors , Melatonin/biosynthesis , Pineal Gland/cytology , Protein Binding , Protein Conformation , Rats , Rhodanine/analogs & derivatives , Rhodanine/chemistry , Rhodanine/pharmacology , Tryptamines/chemistry , Tryptamines/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...